Alnylam Pharmaceuticals Conference Call

• Read more about Alnylam Pharmaceuticals Conference Call

Leerink Partners Rare Disease & Immuno-Oncology Roundtable

• Read more about Leerink Partners Rare Disease & Immuno-Oncology Roundtable

2016 RNAi Roundtable: ALN-GO1 for the treatment of primary hyperoxaluria type 1 (PH1)

• Read more about 2016 RNAi Roundtable: ALN-GO1 for the treatment of primary hyperoxaluria type 1 (PH1)

Bank of America Merrill Lynch Global Healthcare Conference 2016

• Read more about Bank of America Merrill Lynch Global Healthcare Conference 2016

Morgan Stanley Global Healthcare Conference

• Read more about Morgan Stanley Global Healthcare Conference

2016 RNAi Roundtable: ALN-AS1 for the treatment of acute hepatic porphyrias

• Read more about 2016 RNAi Roundtable: ALN-AS1 for the treatment of acute hepatic porphyrias

2016 RNAi Roundtable: ALN-CC5 for the Treatment of Complement-Mediated Diseases

• Read more about 2016 RNAi Roundtable: ALN-CC5 for the Treatment of Complement-Mediated Diseases

2016 RNAi Roundtable: Fitusiran for the Treatment of Hemophilia and Rare Bleeding Disorders

• Read more about 2016 RNAi Roundtable: Fitusiran for the Treatment of Hemophilia and Rare Bleeding Disorders

Canaccord Genuity 36th Annual Growth Conference

• Read more about Canaccord Genuity 36th Annual Growth Conference

Alnylam Pharmaceuticals Q2 2016 Earnings Conference Call

• Read more about Alnylam Pharmaceuticals Q2 2016 Earnings Conference Call